BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29576547)

  • 1. Expression specificity and compensation effect of Ash2l-1/Ash2l-2 in mouse embryonic stem cells.
    Xie J; Fan C; Zhang JL; Zhang SQ
    Yi Chuan; 2018 Mar; 40(3):237-249. PubMed ID: 29576547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequate concentration of B cell leukemia/lymphoma 3 (Bcl3) is required for pluripotency and self-renewal of mouse embryonic stem cells via downregulation of Nanog transcription.
    Kang S; Yun J; Kim DY; Jung SY; Kim YJ; Park JH; Ji ST; Jang WB; Ha J; Kim JH; Baek SH; Kwon SM
    BMB Rep; 2018 Feb; 51(2):92-97. PubMed ID: 29335071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network.
    Tsai PH; Chien Y; Wang ML; Hsu CH; Laurent B; Chou SJ; Chang WC; Chien CS; Li HY; Lee HC; Huo TI; Hung JH; Chen CH; Chiou SH
    Nucleic Acids Res; 2019 Nov; 47(19):10115-10133. PubMed ID: 31555818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism for DPY30 and ASH2L intrinsically disordered regions to modulate the MLL/SET1 activity on chromatin.
    Lee YT; Ayoub A; Park SH; Sha L; Xu J; Mao F; Zheng W; Zhang Y; Cho US; Dou Y
    Nat Commun; 2021 May; 12(1):2953. PubMed ID: 34012049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of OCT4 Ubiquitination Increases OCT4 Protein Stability and ASH2L-B-Mediated H3K4 Methylation Promoting Pluripotency Acquisition.
    Li S; Xiao F; Zhang J; Sun X; Wang H; Zeng Y; Hu J; Tang F; Gu J; Zhao Y; Jin Y; Liao B
    Stem Cell Reports; 2018 Oct; 11(4):973-987. PubMed ID: 30269953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The trithorax group protein Ash2l is essential for pluripotency and maintaining open chromatin in embryonic stem cells.
    Wan M; Liang J; Xiong Y; Shi F; Zhang Y; Lu W; He Q; Yang D; Chen R; Liu D; Barton M; Songyang Z
    J Biol Chem; 2013 Feb; 288(7):5039-48. PubMed ID: 23239880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fgfr3 is a transcriptional target of Ap2delta and Ash2l-containing histone methyltransferase complexes.
    Tan CC; Walsh MJ; Gelb BD
    PLoS One; 2009 Dec; 4(12):e8535. PubMed ID: 20046871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of circadian gene Clock during differentiation of mouse pluripotent stem cells.
    Lu C; Yang Y; Zhao R; Hua B; Xu C; Yan Z; Sun N; Qian R
    Protein Cell; 2016 Nov; 7(11):820-832. PubMed ID: 27664156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity.
    Finley LWS; Vardhana SA; Carey BW; Alonso-Curbelo D; Koche R; Chen Y; Wen D; King B; Radler MR; Rafii S; Lowe SW; Allis CD; Thompson CB
    Nat Cell Biol; 2018 May; 20(5):565-574. PubMed ID: 29662175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBM14 is indispensable for pluripotency maintenance and mesoderm development of mouse embryonic stem cells.
    Chen G; Zhang D; Zhang L; Feng G; Zhang B; Wu Y; Li W; Zhang Y; Hu B
    Biochem Biophys Res Commun; 2018 Jun; 501(1):259-265. PubMed ID: 29729270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARID4B is critical for mouse embryonic stem cell differentiation towards mesoderm and endoderm, linking epigenetics to pluripotency exit.
    Terzi Cizmecioglu N; Huang J; Keskin EG; Wang X; Esen I; Chen F; Orkin SH
    J Biol Chem; 2020 Dec; 295(51):17738-17751. PubMed ID: 33454011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long non-coding RNA Snhg3 is essential for mouse embryonic stem cell self-renewal and pluripotency.
    Lu W; Yu J; Shi F; Zhang J; Huang R; Yin S; Songyang Z; Huang J
    Stem Cell Res Ther; 2019 May; 10(1):157. PubMed ID: 31151411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actl6a protects embryonic stem cells from differentiating into primitive endoderm.
    Lu W; Fang L; Ouyang B; Zhang X; Zhan S; Feng X; Bai Y; Han X; Kim H; He Q; Wan M; Shi FT; Feng XH; Liu D; Huang J; Songyang Z
    Stem Cells; 2015 Jun; 33(6):1782-93. PubMed ID: 25802002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-stranded DNA binding protein Ssbp3 induces differentiation of mouse embryonic stem cells into trophoblast-like cells.
    Liu J; Luo X; Xu Y; Gu J; Tang F; Jin Y; Li H
    Stem Cell Res Ther; 2016 May; 7(1):79. PubMed ID: 27236334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogene Etv5 promotes MET in somatic reprogramming and orchestrates epiblast/primitive endoderm specification during mESCs differentiation.
    Zhang J; Cao H; Xie J; Fan C; Xie Y; He X; Liao M; Zhang S; Wang H
    Cell Death Dis; 2018 Feb; 9(2):224. PubMed ID: 29445086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9-mediated knockout of the Prkdc in mouse embryonic stem cells leads to the modulation of the expression of pluripotency genes.
    Soleimani F; Babaei E; H Feizi MA; Fathi F
    J Cell Physiol; 2020 Apr; 235(4):3994-4000. PubMed ID: 31603250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of embryo cryopreservation on derivation efficiency, pluripotency, and differentiation capacity of mouse embryonic stem cells.
    Assadollahi V; Hassanzadeh K; Abdi M; Alasvand M; Nasseri S; Fathi F
    J Cell Physiol; 2019 Dec; 234(12):21962-21972. PubMed ID: 31081207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma.
    Wu YJ; Ko BS; Liang SM; Lu YJ; Jan YJ; Jiang SS; Shyue SK; Chen L; Liou JY
    Cell Death Dis; 2019 May; 10(6):408. PubMed ID: 31138789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous targeted inhibition of Sox2-Oct4 transcription factors using decoy oligodeoxynucleotides to repress stemness properties in mouse embryonic stem cells.
    Johari B; Zargan J
    Cell Biol Int; 2017 Dec; 41(12):1335-1344. PubMed ID: 28833847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.
    Butler JS; Qiu YH; Zhang N; Yoo SY; Coombes KR; Dent SY; Kornblau SM
    Leuk Lymphoma; 2017 May; 58(5):1207-1218. PubMed ID: 28185526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.